Macrocin-T - Erythromycin (Lotion) | VetSafeCare.Com

Lot.

Macrocin-T

Erythromycin (Lotion) — Synovia pharma plc
2% / lotion

Alternatives

3

Routes

TOP

Presentations

1

Generic profile Browse alternatives View combinations

Presentations

Lotion · 2% / lotion

30 ml

৳200.61

Dose rules

No structured dose rules are linked to this brand yet.

Dose reference

Human

Apply in morning and evening to the affected areas. Before applying thoroughly wash with warm water and soap, rinse and pat dry all areas to be treated. Apply with fingertips or applicator. Wash hands after use. Spread the medication lightly rather than rubbing it in. Acne lesions on the face, neck, shoulders, chest and back may be treated in this manner. Additional containers may be used, if needed. Each container should be used once and discarded.

Clinical notes

Applications:

N/A

Indication Notes:
For topical treatment of acne, pimples & bacterial skin infections susceptible to Erythromycin.
Avoid In:

N/A

Contraindication Notes:
Hypersensitivity to Erythromycin or to any of the other ingredients of the lotion.
Erythromycin is a bacteriostatic macrolide antibiotic. But may be bactericidal in high concentrations. Although the mechanism by which Erythromycin acts in reducing the inflammatory lesions of acne vulgaris is unknown, it is presumably due to the antibiotic action of the drug.
Clindamycin interacts with Erythromycin.
Erythema, desquamation, burning sensation, eye irritation, tenderness, dryness, oily skin etc.
Safety for use during pregnancy has not been established. Use only when the potential benefits outweigh potential hazards to the fetus. Erythromycin is excreted in breast milk. Exercise caution when administering to a nursing mother.
For external use only. Keep away from eyes, nose, mouth and other mucous membrane. Use of antibiotics (especially prolonged or repeated therapy) may result in bacterial or fungal overgrowth of non-susceptible organisms. Such overgrowth may lead to a secondary infection. Take appropriate measures if superinfections occur.
Safety and effectiveness in children less than 12 years have not been established.